Cytokinetics to focus on heart disease drug after ALS trial failure, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

The drug is being developed to treat a heart condition called hypertrophic cardiomyopathies, which causes the thickening of heart muscles and can lead to cardiac arrest. Late-stage data from the drug is expected later this year., The drug is being developed to treat a heart condition called hypertrophic cardiomyopathies, which causes the thickening of heart muscles and can lead to cardiac arrest. Late-stage data from the drug is expected later this year., , Read More